623 related articles for article (PubMed ID: 27349339)
1. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
[TBL] [Abstract][Full Text] [Related]
2. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.
Kammerlander H; Nielsen J; Kjeldsen J; Knudsen T; Friedman S; Nørgård B
Inflamm Bowel Dis; 2017 Jun; 23(6):1011-1018. PubMed ID: 28346274
[TBL] [Abstract][Full Text] [Related]
4. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment.
Bröms G; Granath F; Stephansson O; Kieler H
Scand J Gastroenterol; 2016 Dec; 51(12):1462-1469. PubMed ID: 27739352
[TBL] [Abstract][Full Text] [Related]
5. Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes.
Watanabe C; Nagahori M; Fujii T; Yokoyama K; Yoshimura N; Kobayashi T; Yamagami H; Kitamura K; Takashi K; Nakamura S; Naganuma M; Ishihara S; Esaki M; Yonezawa M; Kunisaki R; Sakuraba A; Kuji N; Miura S; Hibi T; Suzuki Y; Hokari R
Dig Dis Sci; 2021 Feb; 66(2):577-586. PubMed ID: 32249373
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease in pregnancy: a population-based study of prevalence and pregnancy outcomes.
Shand AW; Chen JS; Selby W; Solomon M; Roberts CL
BJOG; 2016 Oct; 123(11):1862-70. PubMed ID: 26924786
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study.
Dominitz JA; Young JC; Boyko EJ
Am J Gastroenterol; 2002 Mar; 97(3):641-8. PubMed ID: 11926208
[TBL] [Abstract][Full Text] [Related]
8. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
[TBL] [Abstract][Full Text] [Related]
10. Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure.
Bröms G; Granath F; Linder M; Stephansson O; Elmberg M; Kieler H
Inflamm Bowel Dis; 2014 Jun; 20(6):1091-8. PubMed ID: 24810137
[TBL] [Abstract][Full Text] [Related]
11. Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
Casanova MJ; Chaparro M; García-Sánchez V; Nantes O; Leo E; Rojas-Feria M; Jauregui-Amezaga A; García-López S; Huguet JM; Arguelles-Arias F; Aicart M; Marín-Jiménez I; Gómez-García M; Muñoz F; Esteve M; Bujanda L; Cortés X; Tosca J; Pineda JR; Mañosa M; Llaó J; Guardiola J; Pérez-Martínez I; Muñoz C; González-Lama Y; Hinojosa J; Vázquez JM; Martinez-Montiel MP; Rodríguez GE; Pajares R; García-Sepulcre MF; Hernández-Martínez A; Pérez-Calle JL; Beltrán B; Busquets D; Ramos L; Bermejo F; Barrio J; Barreiro-de Acosta M; Roncedo O; Calvet X; Hervías D; Gomollón F; Domínguez-Antonaya M; Alcaín G; Sicilia B; Dueñas C; Gutiérrez A; Lorente-Poyatos R; Domínguez M; Khorrami S; Muñoz C; Taxonera C; Rodríguez-Pérez A; Ponferrada A; Van Domselaar M; Arias-Rivera ML; Merino O; Castro E; Marrero JM; Martín-Arranz M; Botella B; Fernández-Salazar L; Monfort D; Opio V; García-Herola A; Menacho M; Ramírez-de la Piscina P; Ceballos D; Almela P; Navarro-Llavat M; Robles-Alonso V; Vega-López AB; Moraleja I; Novella MT; Castaño-Milla C; Sánchez-Torres A; Benítez JM; Rodríguez C; Castro L; Garrido E; Domènech E; García-Planella E; Gisbert JP
Am J Gastroenterol; 2017 Jan; 112(1):120-131. PubMed ID: 27958281
[TBL] [Abstract][Full Text] [Related]
12. Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan.
Naganuma M; Kunisaki R; Yoshimura N; Nagahori M; Yamamoto H; Kimura H; Sako M; Kawaguchi T; Takazoe M; Yamamoto S; Matsui T; Hibi T; Watanabe M
J Crohns Colitis; 2011 Aug; 5(4):317-23. PubMed ID: 21683301
[TBL] [Abstract][Full Text] [Related]
13. Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study.
Kanis SL; de Lima-Karagiannis A; de Boer NKH; van der Woude CJ
Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1232-1241.e1. PubMed ID: 28342949
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcomes in women with inflammatory bowel disease: a 10-year nationwide population-based cohort study.
Lee HH; Bae JM; Lee BI; Lee KM; Wie JH; Kim JS; Cho YS; Jung SA; Kim SW; Choi H; Choi MG
Aliment Pharmacol Ther; 2020 May; 51(9):861-869. PubMed ID: 32266739
[TBL] [Abstract][Full Text] [Related]
15. Influence of medical treatment, smoking and disease activity on pregnancy outcomes in Crohn's disease.
Julsgaard M; Nørgaard M; Hvas CL; Grosen A; Hasseriis S; Christensen LA
Scand J Gastroenterol; 2014 Mar; 49(3):302-8. PubMed ID: 24417179
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
Nørgård B; Pedersen L; Christensen LA; Sørensen HT
Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study.
Bortlik M; Machkova N; Duricova D; Malickova K; Hrdlicka L; Lukas M; Kohout P; Shonova O; Lukas M
Scand J Gastroenterol; 2013 Aug; 48(8):951-8. PubMed ID: 23834232
[TBL] [Abstract][Full Text] [Related]
18. Use of azathioprine and corticosteroids during pregnancy and birth outcome in women diagnosed with inflammatory bowel disease.
Plauborg AV; Hansen AV; Garne E
Birth Defects Res A Clin Mol Teratol; 2016 Jun; 106(6):494-9. PubMed ID: 27301563
[TBL] [Abstract][Full Text] [Related]
19. Maternal Inflammatory Bowel Disease During Pregnancy and Infectious Disease in Offspring Younger Than 5 Years: A Population-Based Cohort Study.
Ren T; Yu Y; Wang H; Li F; Zhang J; Li J
Am J Gastroenterol; 2023 Mar; 118(3):491-500. PubMed ID: 36695745
[TBL] [Abstract][Full Text] [Related]
20. The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD).
Shim L; Eslick GD; Simring AA; Murray H; Weltman MD
J Crohns Colitis; 2011 Jun; 5(3):234-8. PubMed ID: 21575887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
